India's healthcare market is positioned for significant expansion over the next decade, with demand expected to outpace the last 10 years according to The Economic Times. The sector benefits from expanding insurance penetration, tier-two and tier-three city formalisation, and medical tourism returning with an AI edge. These forces create an unusual runway for growth that is unstoppable individually and collectively. As per Motilal Oswal Wealth Management Research Desk, the sector is entering its next growth phase supported by rising healthcare awareness, increasing lifestyle diseases, expanding insurance penetration, and sustained investments in hospital infrastructure. The combination of rapid urbanization, improving affordability, and stronger healthcare accessibility is reinforcing long-term growth visibility.
India's private healthcare sector is experiencing a significant consolidation wave, with hospital chains shifting from building new facilities to acquiring existing ones. According to The Economic Times, this trend, fueled by a decade of private equity funding, aims to address a critical shortage of beds, particularly outside major metros. Major chains are taking notice of the under-served regions, with Max Healthcare announcing a 700-bed hospital in Lucknow and Aster investing in expansion projects of similar scale in the region. The most under-served regions fall within India's Hindi belt, including Uttar Pradesh, Bihar, West Bengal, and Chhattisgarh, where patients can pay for quality care but face bed shortages.
Seven healthcare stocks have been identified with upside potential of up to 25% according to the analysis by The Economic Times. The report emphasizes that healthcare is one of the few sectors where the demand picture for the next 10 years is genuinely larger than the demand picture of the last 10 years. Motilal Oswal recommends Max Healthcare with a target price of ₹1,260 and Global Health (Medanta) with a target price of ₹1,490 as top investment picks. The sector's growth trajectory is supported by the combination of these structural advantages and the favorable market conditions driving expansion across multiple segments, with capacity expansion remaining a defining industry theme as hospital operators focus on enhancing bed capacity and specialized centres of excellence.
Max Healthcare operates a high-acuity multi-specialty hospital network with 4QFY26 revenue growth remaining subdued due to discontinuation of select chemotherapy drugs and softer inpatient volumes. However, stable ARPOB, 75 per cent occupancy and resilient EBITDA per bed supported margin expansion, with the company projecting consolidated revenue/EBITDA/PAT CAGR of 14 per cent/15 per cent/20 per cent over FY26-28. Global Health (Medanta) reported 24.5 per cent YoY revenue growth in 4QFY26 with mature hospitals posting 11 per cent revenue growth and developing hospitals revenue growing 51 per cent YoY. Motilal Oswal estimates a robust 28 per cent earnings CAGR over FY26-28 for Medanta, driven by scaling up of Noida operations and continued capacity additions.
